Capecitabine Tablet
Product Images NDC 82009-112
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Capecitabine (NDC 82009-112). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Quallent Pharmaceuticals Health Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure1 (Figure1)
Figure2 (Figure2)
Figure3 (Figure3)
Figure4 (Figure4)
Figure5 (Figure5)
This text appears to be a prescription or medical treatment plan. It mentions different dosages of medications, such as Docetaxel and Capecitabine, along with the recommended frequency of administration. The dosages are specified in milligrams per square meter of body surface area and the frequency of administration is indicated as either every 3 weeks or twice daily. The last line seems to indicate a time frame, possibly referring to a treatment duration or scheduling. Unfortunately, without further context or clarification, it is not possible to provide a more specific description or interpretation.*
Figure6 (Figure6)
This text appears to be a medication prescription or treatment plan for a group of patients. It includes the dosages and schedules for two drugs: Docetaxel and Capecitabine. The dosage for Docetaxel is 100 mg/sqm every 3 weeks, while Capecitabine is prescribed at 1250 mg/sqm twice daily. There is also mention of intermittent widocetaxel at a dosage of 75 mg/sqm every 3 weeks. The text ends with the number "800" followed by the label "Time (Days)". Based on this information, it seems to be a plan outlining the administration of these medications over a specific period of time.*
Structure (Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.